Litcius/Paper detail

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal, Darren Barton, Diana Hull, Richard Parker, Jonathan Hazlehurst, Kathy Guo, George Abouda, Mark Aldersley, Deborah Stocken, Stephen Gough, Jeremy Tomlinson, Rachel M. Brown, Stefan G. Hübscher, Philip N. Newsome

2015The Lancet2,133 citationsDOIOpen Access PDF

Topics & Concepts

LiraglutideMedicineSteatohepatitisPlaceboInternal medicineFatty liverGastroenterologyClinical trialSteatosisDiabetes mellitusType 2 diabetesSurgeryDiseaseEndocrinologyPathologyAlternative medicineLiver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study | Litcius